The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons

Thrombosis Research
M MochizukiA Takada

Abstract

We investigated the in vitro influence of chylomicron (CM) remnant and very low density lipoprotein (VLDL) remnant on platelet aggregation in healthy persons. The separation of CM and VLDL remnants from serum was performed using an immunoaffinity gel mixture containing anti apo B-100 and anti apo A-1 antibodies coupled to Sepharose 4B. The preincubation with CM and VLDL remnants significantly enhanced the platelet aggregation in whole blood and in platelet rich plasma (PRP) induced by collagen. This effect was observed in whole blood with the addition of VLDL remnant at the concentration of 5 mu g/ml, and in PRP with the addition of CM remnant at the concentration of 1 and 5 mu g/ml, and with the addition of VLDL remnant at the concentration of 5 and 10 mu g/ml. These results may indicate that increase in remnant lipoproteins may be a part of the reasons for atherosclerotic and thrombotic complications.

References

Feb 1, 1975·Annals of Internal Medicine·J MorganrothD S Fredrickson
Sep 1, 1979·Circulation·D B Zilversmit
Dec 1, 1990·Atherosclerosis·H S SimpsonJ Shepherd
Sep 15, 1985·Thrombosis Research·J A JakubowskiF J Morgan
Jul 1, 1988·Seminars in Thrombosis and Hemostasis·J G Brook, M Aviram
Mar 1, 1987·The Biochemical Journal·H E AndrewsK R Bruckdorfer
Jul 1, 1987·Progress in Cardiovascular Diseases·M Aviram, J G Brook
Jul 1, 1986·American Journal of Clinical Pathology·R AbbateD Prisco
Oct 1, 1984·European Journal of Clinical Investigation·A NordøyS Renaud
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J P KaneR J Havel
Mar 1, 1983·Atherosclerosis·M Aviram, J G Brook
Jul 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D G HassallB Lewis
Aug 5, 1982·The New England Journal of Medicine·P J NestelM H Tan
Apr 15, 1995·Thrombosis Research·R KnöflerA Takada
Dec 31, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·K NakajimaE Campos
Nov 30, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·H ShimizuT Saito
Jun 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·N XuA Nilsson
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·G van WilligenJ W Akkerman
Jan 1, 1994·The Medical Clinics of North America·H N Ginsberg
Aug 14, 1995·Clinica Chimica Acta; International Journal of Clinical Chemistry·R KnöflerA Takada
Jan 1, 1994·Journal of Atherosclerosis and Thrombosis·K NakajimaT Murase

❮ Previous
Next ❯

Citations

Nov 13, 2001·European Journal of Ultrasound : Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology·C OttoH Schmid-Schönbein
Feb 24, 2011·European Journal of Human Genetics : EJHG·Asa JohanssonJohn Blangero
Apr 15, 1997·Annals of the New York Academy of Sciences·T NakanoA Takada
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Karl WinklerWinfried März

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.